DEVELOPMENT OF NEW PHARMACEUTICAL PRODUCTS BASED ON THE PLANT OBJECT ELAEAGNUS ANGUSTIFOLIA L.

Аннотация

The increase in chronic diseases, multi-organ pathology, and complications from long-term use of synthetic drugs necessitates the search for alternative sources of medicines with minimal side effects. In this context, interest in herbal medicines with comprehensive effects and good tolerability is growing. Elaeagnus angustifolia (narrow-leaved oleaster) has traditionally been used in folk medicine as an analgesic and anti-inflammatory agent. Modern studies confirm the presence of bioactive compounds (BACs) in this plant, which can serve as the basis for the development of effective and safe pharmaceutical products, exhibiting antioxidant, analgesic, and antibacterial activities.